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Abstract
Background: Japan experienced two rubella outbreaks in the past decade (2004 and 2012 – 2013), resulting in
10 and 20 infants with congenital rubella syndrome (CRS), respectively. This study was performed to determine
whether the seronegative rate was lower in multiparous women than in primiparous women in Japan.
Methods: Hemagglutination inhibition (HI) test results during pregnancy were analyzed retrospectively in 11048
primiparous and 9315 multiparous women who gave birth at six hospitals in northern Japan in the 5-year study
period (January 2008 through December 2012). Women with HI titer < 1:8 were defined as susceptible to rubella.
Results: The seronegative rate was significantly lower in multiparous than primiparous women aged 30 – 31 years
(2.3% [22/967] vs. 4.5% [66/1454], P = 0.0036), 36 – 37 years (3.4% [55/1601] vs. 5.7% [79/1389], P = 0.0030), and
overall women (3.8% [350/9315] aged 34.7 ± 5.2 vs. 5.4% [597/11048] for 33.2 ± 5.9, P < 0.001). The susceptible
fraction size did not differ largely according to hospital, ranging from 3.5% to 6.3%. Those for each year did not
change markedly; 4.5% [150/3369], 5.2% [221/4268], 4.4% [195/4412], 4.6% [186/4056], and 4.6% [195/4258] for 2008,
2009, 2010, 2011, and 2012, respectively. Those for teenagers were consistently high: 22.7% [5/22], 20.7% [6/29],
20.6% [7/34], 13.0% [3/23], and 23.5% [4/17] for 2008, 2009, 2010, 2011, and 2012, respectively.
Conclusions: The seronegative rate was significantly lower in multiparous than primiparous women. However,
Japanese rubella vaccination programs were insufficient to eliminate CRS.
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Background
Public health concern regarding rubella stems from the
teratogenic effects that can result from congenital ru-
bella infection, particularly during the first trimester of
pregnancy. Japan experienced a rubella outbreak in
2004, in which 10 infants contracted congenital rubella
syndrome (CRS) [1]. Supplemental immunization activ-
ity targeting adult women and population immunity sur-
veys were strengthened since the outbreak in 2004.
Japanese guidelines for obstetric practice recommend
determination of immunity status against rubella with
hemagglutination inhibition (HI) test during the first
trimester and postpartum vaccination in women with
low titer of HI test results (≤ 16×) [2].
However, a rubella outbreak occurred again in Japan
in 2012 – 2013 [3]. The total number of rubella patients
in Japan during the first 9 months of 2013 was 14077
(108 per 1000000 population, 69% of cases were sero-
logically confirmed) [3]. Among 14077 patients in this
outbreak, vaccination status was unknown in 8973 pa-
tients. Of 5104 patients with known vaccination status,
924 (18.1%) had been vaccinated, while 4180 (81.9%)
had not been vaccinated [4]. The majority of rubella
cases occurred among adults aged 18 years or older:
male and female adults aged 18 years or older accounted
for 71.7% and 19.8% of all 14077 cases, respectively [3].
Consequently, 20 infants (1.8 per 100000 live births)
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were diagnosed with CRS during the 12-month period
between October 2012 and September 2013 in Japan [3].
The present retrospective and multicenter study was
conducted to determine whether the experience of prior
birth influenced seronegative rate against rubella among
pregnant Japanese women and to assess how many preg-
nant Japanese women were susceptible to rubella during
the rubella outbreak that occurred in Japan in 2012 –
2013.
Methods
This study was conducted after being approved by the
Institutional Review Boards of Hokkaido University
Hospital, Kitasato University Hospital, National Center
for Child Health and Development, Nippon Medical
School Tama-Nagayama Hospital, Jichi Medical Univer-
sity Hospital, and Toyama University Hospital.
This retrospective study included 20363 women, all of
whom fulfilled the following criteria: rubella immunity
was determined in pregnancy by HI test and gave birth
during the 5-year period between January 2008 and
December 2012 at one of following six hospitals loca-
ted in northern Japan: Hokkaido University Hospital,
Toyama University Hospital, Jichi Medical University
Hospital, National Center for Child Health and Develop-
ment, Nippon Medical School Nagayama Hospital, and
Kitasato University Hospital (Table 1). A portion of the
results obtained in this study regarding the overall frac-
tion of pregnant women susceptible to rubella was de-
scribed elsewhere previously [3].
Titer of rubella antibody determined with HI test was
expressed as < 8×, 8×, 16×, 32×, 64×, 128×, 256×, 512×,
1024×, and > 1024×. Women with HI titer < 8× were de-
fined as having no immunity against rubella (susceptible
to rubella) in this study. The correlation between HI titer
(×, [Log2]) and titer (y, IU/mL [Log2]) determined by en-
zyme immunoassay (Siemens Healthcare Japan, Tokyo,
Japan) is as a follows [5]: y = 0.736× + 1.6377.
All data are presented as means ± SD. For statistical
analysis of categorical data, Fisher’s exact test was ap-
plied. The statistical software package StatView 5.0 for
Macintosh (SAS Institute Inc. Cary, NC) was used for all
data analyses. In all analyses, P < 0.05 was taken to indi-
cate statistical significance.
Results
Regional differences in rubella immunity among pregnant
women
Regional differences in size of the fraction susceptible to
rubella (HI titer < 8×) were relatively small: 3.5% (86/
2467) in Region C (Tochigi), 3.5% (257/7329) in Region
D (Tokyo 1), 4.1% (33/803) in Region B (Toyama), 5.4%
(78/1450) in Region A (Hokkaido), 5.6% (263/4672) in
Region F (Kanagawa), and 6.3% (230/3642) in Region E
(Tokyo 2) (Figure 1). Overall, 4.7% (947/20363) of all
pregnant women were susceptible to rubella. Overall
fractions with HI titer 8×, 16×, 32×, 64×, 128×, 256×,
512×, and ≥ 1024× were 4.5% (908/20363), 11.0% (2250/
20363), 21.5% (4381/20363), 25.5% (5201/20363), 18.7%
(3800/20363), 10.1% (2063/20363), 3.5% (715/20363),
and 0.5% (98/20363), respectively.
Fraction of pregnant women susceptible to rubella
according to maternal age and year
The seronegative rates differed greatly between six
groups divided according to maternal age (Figure 2).
Those for younger women were consistently high: 22.7%
[5/22], 20.7%[6/29], 20.6%[7/34], 13.0%[3/23], and 23.5%
[4/17] for teenagers, and 11.9%[17/143], 14.3%[28/196],
10.7%[18/168], 13.5%[19/141], and 12.1%[17/140] for
women aged 20 – 24 years in 2008, 2009, 2010, 2011,
and 2012, respectively. These values decreased with ad-
vancing maternal age, and this trend did not vary with
time. Overall seronegative rates according to maternal
age were as follows [3]: 19.8% [25/126] for women
Table 1 Regions (prefectures) and numbers of pregnant
women tested
Regions (prefectures) Direction from Tokyo No. of women
A (Hokkaido) 830 km N 1450
B (Toyama) 260 km NW 803
C (Tochigi) 100 km N 2467
D (Tokyo 1) 15 km W* 7329
E (Tokyo 2) 40 km W* 3642
F (Kanagawa) 35 km W* 4672
N, north; NW, northwest; W, west; *, from Japan Railroad Tokyo Station.
Figure 1 Regional differences in prevalence rate of pregnant
women susceptible to rubella. A, Hokkaido prefecture; B, Toyama
prefecture; C, Tochigi prefecture, D, Tokyo 1; E, Tokyo 2; and F,
Kanagawa prefecture. Closed, shaded and open bars indicate
hemagglutination inhibition assay (HI) titers of < 8×, 8×, and 16×,
respectively. Total number of pregnant women tested is indicated at
the bottom.
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aged ≤ 19, 12.6% [99/787] for those aged 20 – 24 years,
7.0% [233/3313] for those aged 25 – 29 years, 3.6% [244/
6871] for those aged 30 – 34 years, 3.8% [265/6966] for
those aged 35 – 39 years, and 3.5% [81/2300] for those
aged ≥ 40 years. Overall seronegative rates according to
year did not change greatly: 4.5%[150/3369], 5.2%[221/
4268], 4.4%[195/4412], 4.6%[186/4056], and 4.6%[195/
4258] for 2008, 2009, 2010, 2011, and 2012, respectively.
Effects of a history of prior birth on the prevalence rate
of susceptible pregnant women
Overall, the prevalence rate of susceptibility to rubella was
significantly lower in multiparous than in primiparous
women (Table 2). However, statistically significant differ-
ences in seronegative rate were seen in only a limited
number of areas. Furthermore, significant differences in
seronegative rates were seen in a limited number of
groups of women stratified by age: women aged 30 –
31 years (2.3% [22/967] for multiparous women vs. 4.5%
[66/1454] for primiparous women) and women aged 36 –
37 years (3.4% [55/1601] for multiparous women vs. 5.7%
[79/1389] for primiparous women) (Table 3).
Discussion
This study demonstrated that a history of prior birth
had some favorable effect on reduction in the number of
women susceptible to rubella, although this effect was
limited, and did not prevent the occurrence of CRS.
As Japanese guidelines for obstetric practice recom-
mend determination of rubella immunity during the
1st trimester with HI test [2], a considerable number
of multiparous women with seronegative results (HI
titer < 8×) may have realized that they were susceptible
to rubella in their previous pregnancies. In addition,
as the guidelines recommend postnatal vaccination in
women with seronegative results and low HI titer
(≤ 16×) [2], a very low frequency of susceptible multipar-
ous women was expected in this study. However, the
susceptible fraction decreased only by 30% (from 5.4% to
3.8%) in this study (Table 2). These observations indi-
cated that some women ignored the recommendation
and or some obstetricians forgot to recommend the
postpartum vaccination. Furthermore, there were no sig-
nificant differences in seronegative rates between prim-
iparous and multiparous women in some areas. This
suggested that the strength of vaccination campaigns for
postpartum women with seronegative results differed be-
tween areas. A low postpartum vaccination rate of 11%
among eligible women has also been reported in other
countries [6]. Thus, it was evident based on this study
that some women ignore or underestimate the risk of
rubella infection during subsequent pregnancies even
after the recognition of susceptibility to rubella.
The higher seronegative rate among younger pregnant
women is a cause for concern (Figure 2). Although some
fluctuations in seronegative rate according to year were
seen mainly due to the small size of the study popula-
tion, seronegative rate was consistently high among
teenage pregnant women ranging from 13.0% in 2011 to
23.5% in 2012 and among young women aged 20 –
24 years ranging from 10.7% in 2010 to 14.3% in 2009.
Those women may become pregnant in future. Accor-
ding to the serosurvey conducted by the Japanese
National Institute of Infectious Diseases (JNIID) in the
5-year period between 2008 and 2012, seronegative rate
among females according to age are as follows: 6.7% for
women aged 15 – 19 years, 5.5% for those aged 20 – 24,
4.0% for those aged 25 – 29, 3.6% for those aged 30 – 34,
3.2% (41/1299) for those aged 35 – 39, and 3.9% (64/
1655) for those aged ≥ 40 [7]. Although there was a
large discrepancy in seronegative rate between pregnant
women in this study and female participants in the sero-
survey, especially in younger women, trends such as the
higher seronegative rate in younger women were similar
between the results of the JNIID serosurvery and our
observations. In addition, one in five male Japanese
adults in their 30s and 40s was susceptible to rubella
Figure 2 Prevalence rate of pregnant women susceptible to
rubella (HI titer < 8×) according to maternal age and year.
Table 2 Effects of a history of prior birth on frequency of
susceptible women to rubella according to area
Primiparous Multiparous
Area Age (years) % (a/b)† Age (years) % (a/b)†
A 30.9 ± 5.3 7.0 (57/816) 32.4 ± 4.9 3.3 (21/634)*
B 28.2 ± 4.8 4.8 (20/416) 34.3 ± 4.3* 3.4 (13/387)
C 30.4 ± 7.7 3.7 (46/1252) 33.0 ± 6.6 3.3 (40/1215)
D 33.2 ± 5.9 4.3 (181/4241) 34.2 ± 5.7 2.5 (76/3088)*
E 29.5 ± 5.6 6.4 (132/2070) 33.4 ± 6.4* 6.2 (98/1572)
F 30.2 ± 7.5 7.1 (161/2253) 32.8 ± 6.7* 4.2 (102/2419)*
Overall 33.2 ± 5.9 5.4 (597/11048) 34.7 ± 5.2* 3.8 (350/9315)*
(a/b)†, number of women with HI titer < 8×/total number of women;
*, P < 0.05 vs. corresponding counterpart.
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[3,7]. The large discrepancy in fraction size susceptible
to rubella between younger pregnant women and youn-
ger female participants in the serosurvey by the JNIID
may be explained as follows: the participants in the sero-
survey by the JNIID may have had a greater interest in
healthcare than in the general population and teenage
pregnant Japanese women may have rather constituted a
group at risk for non-vaccination. These speculations
were based on the findings that the risk of no antenatal
care was high among women with teenage pregnancies
in Japan [8], suggesting that women becoming pregnant
as teenagers may have been less likely to receive social
support from the community. The actual percentage of
women susceptible to rubella may have fallen to a figure
intermediate between those of pregnant women and fe-
male participants in the serosurvey. All of these observa-
tions suggested that the current Japanese vaccination
strategy has been ineffective for elimination of CRS.
The current Japanese vaccination strategy is ineffective
for elimination of CRS for several reasons as follows.
With continuing circulation of rubella virus, there is a
persistent risk of infection in susceptible pregnant
women, even when only 2% – 3% of pregnant women
are non-immune [9]. The circulation of rubella virus can
occur in the presence of a low vaccination coverage rate
in some populations in the community [10-12], as was
confirmed in the current outbreak in Japan. The princi-
pal rationale for an accelerated vaccination strategy is to
reduce the time needed to interrupt rubella virus circu-
lation and to prevent CRS [13]. Eradication of only one
manifestation (such as CRS) of a prevalent rubella infec-
tion is not a realistic goal. Samuel and John [14] stated
that “To eliminate CRS, virus transmission should be
interrupted.” Our data combined with those obtained in
the serosurvey and the current outbreak strongly suggest
that more intensified universal vaccination programs tar-
geting adolescents and children are required and that
supplementary immunization activity should be focused
on male adults to interrupt endemic rubella transmis-
sion. Programs to eliminate rubella have indeed been
successful in the USA [15] and appear to have been suc-
cessful in some European countries [16] and the Ameri-
cas [12]. It is necessary to realize that “Treatment of
CRS is costly and rubella vaccination programs are
highly cost-effective” [17].
Japanese guidelines for obstetric practice recommend
taking diagnostic measures in women with HI titer ≥
256× during early pregnancy [2]. The total number of
women with HI titer ≥ 256× was 14.1% (2876/20363) in
this study, consistent with the results of a previous study
conducted in the 3-year period between July 2003 and
June 2006 [18] in which 469 (17.1%) of 2741 women had
HI titers ≥ 256×. In that study, 411 of the 469 women
underwent determination of rubella-specific IgM anti-
body, 6 women exhibit a positive IgM test result, and
none gave birth to a CRS infant [18]. As there are ap-
proximately 1.05 to 1.1 million annual births in Japan,
these results suggested that the number of women
who should undergo determination of rubella-specific
IgM would be approximately 150000 yearly in Japan.
However, only one infant contracted CRS each year
from 2000 to 2003 and 10 infants contracted CRS in
the previous rubella outbreak in 2004 [1]. Although
several infants may be diagnosed early as having CRS
through the diagnostic measures using rubella-specific
IgM for pregnant women with HI titers ≥ 256×, this
strategy for the early detection of CRS may not be
cost-effective.
Table 3 Effects of a history of prior birth on frequency of susceptible women to rubella according to maternal age
No immunity against rubella (HI < 8×)
Age (year) Overall Primiparous Multiparous P-value
≤ 19 25/126 (19.8%) 23/111 (20.7%) 2/15 (13.3%) 0.7335
20 – 21 29/184 (15.8%) 23/141 (16.3%) 6/43 (14.0%) 0.7102
22 – 23 43/335 (12.8%) 30/236 (12.7%) 13/99 (13.1%) 0.9166
24 – 25 57/642 (8.9%) 37/451 (8.2%) 20/191 (10.5%) 0.3558
26 – 27 101/1171 (8.6%) 72/816 (8.8%) 29/355 (8.2%) 0.7138
28 – 29 100/1768 (5.7%) 69/1132 (6.1%) 31/636 (5.0%) 0.3549
30 – 31 88/2421 (3.6%) 66/1454 (4.5%) 22/967 (2.3%) 0.0036
32 – 33 103/2881 (3.6%) 60/1484 (4.0%) 43/1397 (3.1%) 0.1632
34 – 35 105/3184 (3.4%) 54/1556 (3.5%) 51/1628 (3.3%) 0.7366
36 – 37 134/2990 (4.5%) 79/1389 (5.7%) 55/1601 (3.4%) 0.0030
38 – 39 81/2363 (3.5%) 43/1105 (3.9%) 38/1258 (3.2%) 0.3484
40 – 49 81/2298 (3.5%) 41/1173 (3.4%) 40/1125 (3.6%) 0.8491
Overall 947/20363 (4.7%) 597/11048 (5.4%) 350/9315 (3.8%) < 0.0001
The mean (SD) age was 33.2 ± 5.9 for the 11048 primiparous women and 34.7 ± 5.2 for the 9315 multiparous women (P < 0.0001).
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Conclusion
The experience of prior birth may have favorably affected
the reduction in number of pregnant women susceptible
to rubella. Only 4.7% (947/20363) of all pregnant women
were susceptible to rubella. However, 20 infants with CRS
were born during the 12-month period between October
2012 and September 2013 in Japan [3]. Younger women
less than 25 years old are more susceptible to rubella than
other women of more advanced age. There is still a large
fraction of male adults susceptible to rubella in Japan. We
may have another rubella outbreak in the near future un-
less a new vaccination strategy is implemented for the
elimination of rubella in Japan.
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